Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Gabaldó Barrios X, Sarabia Meseguer MD, Marín Vera M, Sánchez Bermúdez AI, Macías Cerrolaza JA, Sánchez Henarejos P, Zafra Poves M, García Hernández MR, Cuevas Tortosa E, Aliaga Baño Á, Castillo Guardiola V, Martínez Hernández P, Tovar Zapata I, Martínez Barba E, Ayala de la Peña F, Alonso Romero JL, Noguera Velasco JA, Ruiz Espejo F. Gabaldó Barrios X, et al. Among authors: ayala de la pena f. Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x. Fam Cancer. 2017. PMID: 28477318
Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis.
García Garre E, Luengo Gil G, Montoro García S, Gonzalez Billalabeitia E, Zafra Poves M, García Martinez E, Roldán Schilling V, Navarro Manzano E, Ivars Rubio A, Lip GYH, Ayala de la Peña F. García Garre E, et al. Among authors: ayala de la pena f. Breast Cancer Res Treat. 2018 May;169(1):83-92. doi: 10.1007/s10549-017-4656-z. Epub 2018 Jan 16. Breast Cancer Res Treat. 2018. PMID: 29340882
A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge.
Vicente Conesa MA, Zafra Poves M, Carmona-Bayonas A, Ballester Navarro I, de la Morena Barrio P, Ivars Rubio A, Montenegro Luis S, García Garre E, Vicente V, Ayala de la Peña F. Vicente Conesa MA, et al. Among authors: de la morena barrio p, ayala de la pena f. ESMO Open. 2022 Feb;7(1):100384. doi: 10.1016/j.esmoop.2022.100384. Epub 2022 Feb 7. ESMO Open. 2022. PMID: 35144121 Free PMC article.
Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance.
Castillo-Guardiola V, Rosado-Jiménez L, Sarabia-Meseguer MD, Marín-Vera M, Macías-Cerrolaza JA, García-Hernández R, Zafra-Poves M, Sánchez-Henarejos P, Moreno-Locubiche MÁ, Cuevas-Tortosa E, Arnaldos-Carrillo M, Ayala de la Peña F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Castillo-Guardiola V, et al. Among authors: ayala de la pena f. Eur J Med Genet. 2022 Apr;65(4):104468. doi: 10.1016/j.ejmg.2022.104468. Epub 2022 Mar 1. Eur J Med Genet. 2022. PMID: 35245693
Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.
Rosado-Jiménez L, Mestre-Terkemani Y, García-Aliaga Á, Marín-Vera M, Macías-Cerrolaza JA, Sarabia-Meseguer MD, García-Hernández MR, Zafra-Poves M, Sánchez-Henarejos P, Ayala de la Peña F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Rosado-Jiménez L, et al. Among authors: ayala de la pena f. Adv Lab Med. 2023 Sep 22;4(3):279-287. doi: 10.1515/almed-2023-0103. eCollection 2023 Sep. Adv Lab Med. 2023. PMID: 38075165 Free PMC article.
Variantes genéticas recurrentes y priorización de variantes de significado clínico desconocido asociadas al síndrome de cáncer de mama y ovario hereditario en familias de la Región de Murcia.
Rosado-Jiménez L, Mestre-Terkemani Y, García-Aliaga Á, Marín-Vera M, Macías-Cerrolaza JA, Sarabia-Meseguer MD, García-Hernández MR, Zafra-Poves M, Sánchez-Henarejos P, Ayala de la Peña F, Alonso-Romero JL, Noguera-Velasco JA, Ruiz-Espejo F. Rosado-Jiménez L, et al. Among authors: ayala de la pena f. Adv Lab Med. 2023 Jul 10;4(3):288-297. doi: 10.1515/almed-2023-0032. eCollection 2023 Sep. Adv Lab Med. 2023. PMID: 38075173 Free PMC article. Spanish.
Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis.
Luengo-Gil G, González-Billalabeitia E, Chaves-Benito A, García Martínez E, García Garre E, Vicente V, Ayala de la Peña F. Luengo-Gil G, et al. Among authors: ayala de la pena f. Breast Cancer Res Treat. 2015 Jun;151(3):577-87. doi: 10.1007/s10549-015-3421-4. Epub 2015 May 13. Breast Cancer Res Treat. 2015. PMID: 25967462
SEOM clinical guidelines in early stage breast cancer (2018).
Ayala de la Peña F, Andrés R, Garcia-Sáenz JA, Manso L, Margelí M, Dalmau E, Pernas S, Prat A, Servitja S, Ciruelos E. Ayala de la Peña F, et al. Clin Transl Oncol. 2019 Jan;21(1):18-30. doi: 10.1007/s12094-018-1973-6. Epub 2018 Nov 15. Clin Transl Oncol. 2019. PMID: 30443868 Free PMC article.
Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, Chaves-Benito A, Garcia-Martinez E, Garcia-Garre E, Vicente V, Ayala de la Peña F. Luengo-Gil G, et al. Among authors: ayala de la pena f. PLoS One. 2018 Apr 4;13(4):e0194638. doi: 10.1371/journal.pone.0194638. eCollection 2018. PLoS One. 2018. PMID: 29617404 Free PMC article.
Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients.
Carmona-Bayonas A, Gómez J, González-Billalabeitia E, Canteras M, Navarrete A, Gonzálvez ML, Vicente V, Ayala de la Peña F. Carmona-Bayonas A, et al. Among authors: ayala de la pena f. Br J Cancer. 2011 Aug 23;105(5):612-7. doi: 10.1038/bjc.2011.284. Epub 2011 Aug 2. Br J Cancer. 2011. PMID: 21811253 Free PMC article.
49 results